Skip to content
Biosimilars expected to boom in 2023-27, says report
According to a recent report from IQVIA, the market for biosimilars, which mimic ...
Read More
Gilead’s anti-COVID Veklury reduces risk of death
Starting Veklury (remdesivir) within the first two days of hospitalization for COVID-19 can ...
Read More
Pfizer’s RSV vaccine for infants could be approved this summer
Pfizer’s vaccine aimed at protecting infants against severe respiratory syncytial virus (RSV) could ...
Read More
Acceligen’s gene-edited calf less susceptible to BVDV
Biotechnology Innovation Organization (BIO) member Acceligen partnered with the USDA’s Agricultural Research Service ...
Read More
NCBA understands that, in Black America, health care is holistic
“You know,” Karyne Jones laughs, “I am about the same age as many ...
Read More
Biotech helps to fight climate change with carbon-devouring GM trees
A California biotech company seeking to help fight climate change is using the ...
Read More
EDITORS' CHOICE
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Read More
LATEST NEWS
Federal Policy
BIO Coffee Chat: MFN proposals would harm innovation and access
Most Favored Nation (MFN) type drug pricing proposals that were proposed by the Centers for Medicare & Medicaid Innovation (CMMI) in December 2025 would weaken ...
Editors' Choice
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Federal Policy
NIH Director says no studies link vaccines and autism in hearing on modernization
National Institutes of Health (NIH) Director Jay Bhattacharya acknowledged there are no studies indicating a link between any vaccine and autism as Senators pushed for ...
Editors' Choice
BIO lauds passage of PPRV reauthorization and legislation on PBM reform
The Biotechnology Innovation Organization (BIO) hailed inclusion of a bill to encourage new treatments for children with rare diseases and measures targeting reform of pharmacy ...
Federal Policy
BIO tells Congress how to maintain US biotech leadership
Maintaining a world-leading biotech industry keeps Americans safer and its economy stronger. Appropriate federal actions can support this leadership, the Biotechnology Innovation Organization (BIO) said ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another ...
Read More
International
Bio's View
BIO Investment Council will bring together VC and small biotechs to boost innovation
In an initiative to accelerate capital formation for biotech innovation, the Biotechnology Innovation Organization (BIO) on Jan. 7 launched the ...
Read More
